Researchers can now directly convert adult human blood cells to both central nervous system (brain and spinal cord) neurons as well as neurons in the peripheral nervous system (rest of the body) that are responsible for pain, temperature and itch perception.
This means that how a person's nervous system cells react and respond to stimuli, can be determined from his blood, researchers said.
The breakthrough was led by Mick Bhatia, director of the Stem Cell and Cancer Research Institute at McMaster University.
The peripheral nervous system is made up of different types of nerves - some are mechanical (feel pressure) and others detect temperature (heat).
In extreme conditions, pain or numbness is perceived by the brain using signals sent by these peripheral nerves.
"The problem is that unlike blood, a skin sample or even a tissue biopsy, you can't take a piece of a patient's neural system. It runs like complex wiring throughout the body and portions cannot be sampled for study," said Bhatia.
"Nobody has ever done this with adult blood. Ever," Bhatia said.
"We can actually take a patient's blood sample, as routinely performed in a doctor's office, and with it we can produce one million sensory neurons, that make up the peripheral nerves in short order with this new approach.
We can also make central nervous system cells, as the blood to neural conversion technology we developed creates neural stem cells during the process of conversion," said Bhatia.
It also paves the way for the discovery of new pain drugs that don't just numb the perception of pain, Bhatia said.
Bhatia's team successfully tested their process using fresh blood, but also cryopreserved (frozen) blood.
Since blood samples are taken and frozen with many clinical trials, this allows them "almost a bit of a time machine" to go back and explore questions around pain or neuropathy to run tests on neurons created from blood samples of patients taken in past clinical trials where responses and outcomes have already been recorded."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
